Logo image of ASL.CA

ARGENTUM SILVER CORP (ASL.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:ASL - CA04014D2068 - Common Stock

0.14 CAD
+0.02 (+16.67%)
Last: 1/12/2026, 7:00:00 PM
Fundamental Rating

1

ASL gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 813 industry peers in the Metals & Mining industry. ASL has a bad profitability rating. Also its financial health evaluation is rather negative. ASL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ASL had negative earnings in the past year.
In the past year ASL has reported a negative cash flow from operations.
In the past 5 years ASL always reported negative net income.
In the past 5 years ASL always reported negative operating cash flow.
ASL.CA Yearly Net Income VS EBIT VS OCF VS FCFASL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500K -1M -1.5M

1.2 Ratios

Looking at the Return On Assets, with a value of -242.86%, ASL is doing worse than 82.78% of the companies in the same industry.
Industry RankSector Rank
ROA -242.86%
ROE N/A
ROIC N/A
ROA(3y)-178.27%
ROA(5y)-119.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASL.CA Yearly ROA, ROE, ROICASL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

1.3 Margins

ASL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASL.CA Yearly Profit, Operating, Gross MarginsASL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

1

2. Health

2.1 Basic Checks

ASL has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ASL has more shares outstanding
There is no outstanding debt for ASL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ASL.CA Yearly Shares OutstandingASL.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ASL.CA Yearly Total Debt VS Total AssetsASL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200K 400K 600K 800K 1M

2.2 Solvency

ASL has an Altman-Z score of -174.21. This is a bad value and indicates that ASL is not financially healthy and even has some risk of bankruptcy.
ASL's Altman-Z score of -174.21 is on the low side compared to the rest of the industry. ASL is outperformed by 84.99% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -174.21
ROIC/WACCN/A
WACCN/A
ASL.CA Yearly LT Debt VS Equity VS FCFASL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500K -500K

2.3 Liquidity

ASL has a Current Ratio of 0.26. This is a bad value and indicates that ASL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ASL (0.26) is worse than 75.89% of its industry peers.
A Quick Ratio of 0.26 indicates that ASL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.26, ASL is doing worse than 74.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.26
ASL.CA Yearly Current Assets VS Current LiabilitesASL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200K 400K 600K 800K 1M

More info and screens

1

3. Growth

3.1 Past

ASL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.58%, which is quite impressive.
EPS 1Y (TTM)29.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ASL.CA Price Earnings VS Forward Price EarningsASL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASL.CA Per share dataASL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0 -0 -0 -0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ARGENTUM SILVER CORP

TSX-V:ASL (1/12/2026, 7:00:00 PM)

0.14

+0.02 (+16.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-21 2025-11-21
Earnings (Next)02-24 2026-02-24
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.22M
Revenue(TTM)N/A
Net Income(TTM)-253.30K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -242.86%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-178.27%
ROA(5y)-119.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.26
Altman-Z -174.21
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y66.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.93%
OCF growth 3YN/A
OCF growth 5YN/A

ARGENTUM SILVER CORP / ASL.CA FAQ

What is the ChartMill fundamental rating of ARGENTUM SILVER CORP (ASL.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ASL.CA.


What is the valuation status for ASL stock?

ChartMill assigns a valuation rating of 0 / 10 to ARGENTUM SILVER CORP (ASL.CA). This can be considered as Overvalued.


How profitable is ARGENTUM SILVER CORP (ASL.CA) stock?

ARGENTUM SILVER CORP (ASL.CA) has a profitability rating of 0 / 10.